The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Cimadomo, Danilo ^a,b   Capalbo, Antonio ^a,c   Ubaldi, Filippo Maria ^a,c   Scarica, Catello ^a,b   Palagiano, Antonio ^d   Canipari, Rita ^b   Rienzi, Laura ^a,c  

^a GENERA Centre for Reproductive Medicine   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Gruppo Salus   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BLASTOCYST; BLASTOCYST STAGE BIOPSY; CLEAVAGE STAGE BIOPSY; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; META ANALYSIS (TOPIC); MORULA; MORULA STAGE BIOPSY; NONHUMAN; POLAR BODY; POLAR BODY BIOPSY; PREIMPLANTATION GENETIC DIAGNOSIS; PRENATAL DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; CHROMOSOME ABERRATION; CYTOLOGY; EMBRYO TRANSFER; FEMALE; GENETIC SCREENING; NIDATION; PREGNANCY; PROCEDURES;

BIOPSY; BLASTOCYST; CHROMOSOME ABERRATIONS; EMBRYO IMPLANTATION; EMBRYO TRANSFER; EMBRYONIC DEVELOPMENT; FEMALE; GENETIC TESTING; HUMANS; POLAR BODIES; PREGNANCY; PREIMPLANTATION DIAGNOSIS;

EID: 84958073835     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/7193075     Document Type: Review

References (81)

1. E. Coonen, M. De Rycke, G. Kokkali et al., Data from the ESHRE PGD Consortium, ESHRE Abstract Book, Annual Meeting, 2015.
2. C. Moutou, V. Goossens, E. Coonen et al., "ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010," Human Reproduction, vol. 29, no. 5, pp. 880-903, 2014.
3. J. Traeger-Synodinos, E. C. Coonen, M. De Rycke et al., Data from the ESHRE PGD Consortium, ESHRE Abstract Book, Annual Meeteing, 2014.
4. S. Mastenbroek, M. Twisk, F. van der Veen, and S. Repping, "Preimplantation genetic screening: a systematic review and meta-analysis of RCTs," Human Reproduction Update, vol. 17, no. 4, pp. 454-466, 2011.
5. J. C. Dumoulin, M. Bras, E. Coonen, J. Dreesen, J. P. Geraedts, and J. L. Evers, "Effect of Ca2+/Mg2+-free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos," Human Reproduction, vol. 13, no. 10, pp. 2880-2883, 1998.
6. H. P. M. Pratt, C. A. Ziomek, W. J. D. Reeve, and M. H. Johnson, "Compaction of the mouse embryo: an analysis of its components," Journal of Embryology and Experimental Morphology, vol. 70, pp. 113-132, 1982.
7. L. Clayton, S. V. Stinchcombe, and M. H. Johnson, "Cell surface localisation and stability of uvomorulin during early mouse development," Zygote, vol. 1, no. 4, pp. 333-344, 1993.
8. M. Sefton, M. H. Johnson, L. Clayton, and J. M. L. McConnell, "Experimental manipulations of compaction and their effects on the phosphorylation of uvomorulin," Molecular Reproduction and Development, vol. 44, no. 1, pp. 77-87, 1996.
9. 2+ and relocation of E-cadherin during experimental decompaction of mouse embryos," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 12977-12982, 1998.
10. W. Feichtinger, H. Strohmer, P. Fuhrberg et al., "Photoablation of oocyte zona pellucida by erbium-YAG laser for in-vitro fertilisation in severe male infertility," The Lancet, vol. 339, no. 8796, p. 811, 1992.
11. J. Cohen, C. Elsner, H. Kort, H. Malter, J. Massey, and M. P. Mayer, "Immunosuppression supports implantation of zona pellucida dissected human embryos," Fertility and Sterility, vol. 53, no. 4, pp. 662-665, 1990.
12. J. Cohen, "Assisted hatching of human embryos," Journal of In Vitro Fertilization and Embryo Transfer, vol. 8, no. 4, pp. 179-190, 1991.
13. T. Eldar-Geva, N. Srebnik, G. Altarescu et al., "Neonatal outcome after preimplantation genetic diagnosis," Fertility and Sterility, vol. 102, no. 4, pp. 1016-1021, 2014.
14. A. De Vos and A. Van Steirteghem, "Aspects of biopsy procedures prior to preimplantation genetic diagnosis," Prenatal Diagnosis, vol. 21, no. 9, pp. 767-780, 2001.
15. S. Geber, R. Bossi, C. B. Lisboa, M. Valle, and M. Sampaio, "Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study," Reproductive Biology and Endocrinology, vol. 28, no. 9, p. 58, 2011.
16. A. E. Jones, G. Wright, H. I. Kort, R. J. Straub, and Z. P. Nagy, "Comparison of laser-assisted hatching and acidified Tyrode's hatching by evaluation of blastocyst development rates in sibling embryos: a prospective randomized trial," Fertility and Sterility, vol. 85, no. 2, pp. 487-491, 2006.
17. K. Rink, G. Delacrétaz, R.P. Salathé et al., "Non-contact microdrilling of mouse zona pellucida with an objective-delivered 1.48 μm diode laser," Lasers in Surgery and Medicine, vol. 18, no. 1, pp. 52-62, 1996.
18. T. H. Taylor, J. W. Gilchrist, S. V. Hallowell et al., "The effects of different laser pulse lengths on the embryo biopsy procedure and embryo development to the blastocyst stage," Journal of Assisted Reproduction and Genetics, vol. 27, no. 11, pp. 663-667, 2010.
19. H. E. Malter and J. Cohen, "Blastocyst formation and hatching in vitro following zona drilling of mouse and human embryos," Gamete Research, vol. 24, no. 1, pp. 67-80, 1989.
20. J. Cohen and D. Feldberg, "Effects of the size and number of zona pellucida openings on hatching and trophoblast out-growth in the mouse embryo," Molecular Reproduction and Development, vol. 30, no. 1, pp. 70-78, 1991.
21. F. Schmoll, H. Schneider, M. Montag, K. Wimmers, K. Rink, and K. Schellander, "Effects of different laser-drilled openings in the zona pellucida on hatching of in vitro-produced cattle blastocysts," Fertility and Sterility, vol. 80, supplement 2, pp. 714-719, 2003.
22. F. E. Duncan, P. Stein, C. J. Williams, and R. M. Schultz, "The effect of blastomere biopsy on preimplantation mouse embryo development and global gene expression," Fertility and Sterility, vol. 91, no. 4, pp. 1462-1465, 2009.
23. K. Kirkegaard, J. J. Hindkjaer, and H. J. Ingerslev, "Human embryonic development after blastomere removal: a time-lapse analysis," Human Reproduction, vol. 27, no.1, pp. 97-105, 2012.
24. D. Brodie, C. E. Beyer, E. Osborne, V. Kralevski, S. Rasi, and T. Osianlis, "Preimplantation genetic diagnosis for chromosome rearrangements - one blastomere biopsy versus two blastomere biopsy," Journal of Assisted Reproduction and Genetics, vol. 29, no. 8, pp. 821-827, 2012.
25. G. Harton, J. Traeger-Syndinos, and V. Goossens, "Data from the ESHRE PGD consortium," Human Reproduction, vol. 27, supplement 2, p. ii58, 2012.
26. S. Munné, K. M. Sultan, H. U. Weier, J. A. Grifo, J. Cohen, and Z. Rosenwaks, "Assessment of numeric abnormalities of X, Y, 18, and 16 chromosomes in preimplantation human embryos before transfer," American Journal of Obstetrics and Gynecology, vol. 172, no. 4, part 1, pp. 1191-1199, 1995.
27. D. Wells and J. D. A. Delhanty, "Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization," Molecular Human Reproduction, vol. 6, no. 11, pp.1055-1062, 2000.
28. L. Voullaire, H. Slater, R. Williamson, and L. Wilton, "Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization," Human Genetics, vol. 106, no. 2, pp. 210-217, 2000.
29. M. Bielanska, S. L. Tan, and A. Ao, "Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome," Human Reproduction, vol. 17, no. 2, pp. 413-419, 2002.
30. S. J. McArthur, D. Leigh, J. T. Marshall, K. A. De Boer, and R. P. S. Jansen, "Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts," Fertility and Sterility, vol. 84, no. 6, pp. 1628-1636, 2005.
31. J. Cohen, D. Wells, and S. Munné, "Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates," Fertility and Sterility, vol. 87, no. 3, pp. 496-503, 2007.
32. J. Cieslak-Janzen, I. Tur-Kaspa, Y. Ilkevitch, A. Bernal, R. Morris, and Y. Verlinsky, "Multiple micromanipulations for preimplantation genetic diagnosis do not affect embryo development to the blastocyst stage," Fertility and Sterility, vol. 85, no. 6, pp. 1826-1829, 2006.
33. K. Hardy, K. L. Martin, H. J. Leese, R. M. L. Winston, and A. H. Handyside, "Human preimplantation development in vitro is not adversely affected by biopsy at the 8-cell stage," Human Reproduction, vol. 5, no. 6, pp. 708-714, 1990.
34. V. Goossens, M. De Rycke, A. De Vos et al., "Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis," Human Reproduction, vol. 23, no. 3, pp. 481- 492, 2008.
35. L. Rienzi, F. Ubaldi, M. Iacobelli et al., "Developmental potential of fully intact and partially damaged cryopreserved embryos after laser-assisted removal of necrotic blastomeres and post-thaw culture selection," Fertility and Sterility, vol. 84, no. 4, pp. 888-894, 2005.
36. G. L. Harton, M. C. Magli, K. Lundin, M. Montag, J. Lemmen, and J. C. Harper,"ESHRE PGD Consortium/Embryology Special Interest Group - best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS)," Human Reproduction, vol. 26, no. 1, pp. 41-46, 2011.
37. R. T. Scott Jr., K. M. Upham, E. J. Forman, T. Zhao, and N. R. Treff, "Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial," Fertility and Sterility, vol. 100, no. 3, pp. 624-630, 2013.
38. C. Staessen, W. Verpoest, P. Donoso et al., "Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer," Human Reproduction, vol. 23, no. 12, pp. 2818-2825, 2008.
39. S. Debrock, C. Melotte, C. Spiessens et al., "Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial," Fertility and Sterility, vol. 93, no. 2, pp. 364-373, 2010.
40. T. Hardarson, C. Hanson, K. Lundin et al., "Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial," Human Reproduction,vol. 23, no. 12, pp. 2806-2812, 2008.
41. E. Fragouli, M. Katz-Jaffe, S. Alfarawati et al., "Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure," Fertility and Sterility, vol. 94, no. 3, pp. 875-887, 2010.
42. M. Montag, M. Köster, T. Strowitzki, and B. Toth, "Polar body biopsy," Fertility and Sterility, vol. 100, no. 3,pp. 603-607, 2013.
43. A. Capalbo, S. Bono, L. Spizzichino et al., "Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development," Human Reproduction, vol. 28, no. 2, pp. 509-518, 2013.
44. M. Montag, K. van der Ven, B. Rösing, and H. van der Ven, "Polar body biopsy: a viable alternative to preimplantation genetic diagnosis and screening," Reproductive BioMedicine Online, vol. 18, no. 1, pp. 6-11, 2009.
45. M. C. Magli, M. Montag, M. Kster et al., "Polar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspects," Human Reproduction, vol. 26, no. 11, pp. 3181-3185, 2011.
46. M. Montag, K. van der Ven, G. Delacretaz, K. Rink, and H. van der Ven, "Laser-assisted microdissection of the zona pellucida facilitates polar body biopsy," Fertility and Sterility, vol. 69, no. 3, pp. 539-542, 1998.
47. I. Hammoud, D. Molina-Gomes, M. Albert et al., "Are zona pellucida laser drilling and polar body biopsy safe for in vitro matured oocytes?" Journal of Assisted Reproduction and Genetics, vol. 27, no. 7, pp. 423-427, 2010.
48. I. Levin, B. Almog, T. Shwartz et al., "Effects of laser polar-body biopsy on embryo quality," Fertility and Sterility, vol. 97, no. 5, pp. 1085-1088, 2012.
49. K. L. Scott, K. H. Hong, and R. T. Scott Jr., "Selecting the optimal time to perform biopsy for preimplantation genetic testing," Fertility and Sterility, vol. 100, no. 3, pp. 608-614, 2013.
50. L. Albricci, S. Romano, R. Maggiulli et al., Use of Polarized Light Microscopi to Assess Meiotic Spindle Configuration Prior to 1PB Biopsy for PGD, ESHRE Abstract Book, Annual Meeting, 2009.
51. E. E. Zakharova, V. V. Zaletova, and A. S. Krivokharchenko, "Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS," PLoS ONE, vol. 9, no. 9, Article ID e106433, 2014.
52. K. A. de Boer, J. W. Catt, R. P. S. Jansen, D. Leigh, and S. McArthur, "Moving to blastocyst biopsy for preimplantation genetic diagnosis and single embryo transfer at Sydney IVF," Fertility and Sterility, vol. 82, no. 2, pp. 295-298, 2004.
53. G. Kokkali, C. Vrettou, J. Traeger-Synodinos et al., "Birth of a healthy infant following trophectoderm biopsy from blastocysts for PGD of β-thalassaemia major: case report," Human Reproduction, vol. 20, no. 7, pp. 1855-1859, 2005.
54. D. Glujovsky, D. Blake, C. Farquhar, and A. Bardach, "Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology," Cochrane Database Systematic Reviews, vol. 11, no. 7, Article ID CD002118, 2012.
55. W. B. Schoolcraft, E. Fragouli, J. Stevens, S. Munne, M. G. Katz-Jaffe, and D. Wells, "Clinical application of comprehensive chromosomal screening at the blastocyst stage," Fertility and Sterility, vol. 94, no. 5, pp. 1700-1706, 2010.
56. S. J. McArthur, D. Leigh, J. T. Marshall, A. J. Gee, K. A. De Boer, and R. P. S. Jansen, "Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations," Prenatal Diagnosis, vol. 28, no. 5, pp. 434-442, 2008.
57. A. Cobo, M. J. de los Santos, D. Castellò, P. Gámiz, P. Campos, and J. Remohí, "Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles," Fertility and Sterility, vol. 98, no. 5, pp. 1138.e1-1146.e1, 2012.
58. A. Capalbo, N. R. Treff, D. Cimadomo et al., "Comparison of array comparative genomic hybridization and quantitative realtime PCR-based aneuploidy screening of blastocyst biopsies," European Journal of Human Genetics, vol. 23, no. 7, pp. 901-906, 2015.
59. F. M. Ubaldi, A. Capalbo, S. Colamaria et al., "Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study," Human Reproduction, vol. 30, no. 9, pp. 2097-2106, 2015.
60. B. S. Shapiro, S. T. Daneshmand, H. Restrepo, F. C. Garner, M. Aguirre, and C. Hudson, "Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles," Fertility and Sterility, vol. 99, no. 2, pp. 389-392, 2013.
61. E. J. Forman, K. H. Hong, K. M. Ferry et al., "In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial," Fertility and Sterility, vol. 100, no. 1, pp. 100-107.e1, 2013.
62. E. J. Forman, K. H. Hong, J. M. Franasiak, and R. T. Scott Jr., "Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates," American Journal of Obstetrics and Gynecology, vol. 210, no. 2, pp.157.e1-157.e6, 2014.
63. E. M. Dahdouh, J. Balayla, and J. A. García-Velasco, "Comprehensive chromosome screening improves embryo selection: a meta-analysis," Fertility and Sterility, vol. 104, no. 6, pp. 1503- 1512, 2015.
64. E. M. Dahdouh, J. Balayla, and F. Audibert, "Technical update: preimplantation genetic diagnosis and screening," Journal of Obstetrics and Gynaecology Canada, vol. 37, no. 5, pp. 451-463, 2015.
65. E. Lee, P. Illingworth, L. Wilton, and G. M. Chambers, "The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review," Human Reproduction, vol. 30, no. 2, pp. 473-483, 2015.
66. R. T. Scott Jr., K. Ferry, J. Su, X. Tao, K. Scott, and N. R. Treff, "Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, non-selection study," Fertility and Sterility, vol. 97,no. 4, pp. 870-875, 2012.
67. A. Capalbo, L. Rienzi, D. Cimadomo et al., "Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts," Human Reproduction, vol. 29, no. 6, pp. 1173-1181, 2014.
68. A. Capalbo, F. M. Ubaldi, D. Cimadomo et al., "Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies," Human Reproduction, vol. 31, no. 1, pp. 199-208, 2015.
69. Z. Yang, J. Liu, G. S. Collins et al., "Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study," Molecular Cytogenetics, vol. 5, no. 1, p. 24, 2012.
70. S. Alfarawati, E. Fragouli, P. Colls et al., "The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender," Fertility and Sterility, vol. 95, no. 2, pp. 520-524, 2011.
71. Z. Yang, J. Zhang, S. A. Salem et al., "Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytes," BMC Medical Genomics, vol. 7, article 38, 2014.
72. L. Rienzi, A. Capalbo, M. Stoppa et al., "No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort study," Reproductive BioMedicine Online, vol. 30, no. 1, pp. 57-66, 2015.
73. D. J. Kaser and C. Racowsky, "Clinical outcomes following selection of human preimplantation embryos with time-lapse monitoring: a systematic review," Human Reproduction Update, vol. 20, no. 5, Article ID dmu023, pp. 617-631, 2014.
74. K. Kirkegaard, A. S. P. Svane, J. S. Nielsen, J. J. Hindkjær, N. C. Nielsen, and H. J. Ingerslev, "Nuclear magnetic resonance metabolomic profiling of Day 3 and 5 embryo culture medium does not predict pregnancy outcome in good prognosis patients: a prospective cohort study on single transferred embryos," Human Reproduction, vol. 29, no. 11, pp. 2413-2420, 2014.
75. T. Hardarson, A. Ahlström, L. Rogberg et al., "Non-invasive metabolomic profiling of Day 2 and 5 embryo culture medium: a prospective randomized trial," Human Reproduction, vol. 27, no. 1, pp. 89-96, 2012.
76. M. S. Verp, "Prenatal diagnosis of genetic disorders," in Principles and Practice of Medical Therapy in Pregnancy, N.Gleicher, Ed., pp. 159-170, Appleton and Lange, Norwalk, Conn, USA, 2nd edition, 1992.
77. G. Schemmer and A. Johnson, "Genetic amniocentesis and chorionic villus sampling," Obstetrics & Gynecology Clinics of North America, vol. 20, no. 3, pp. 497-521, 1993.
78. A. B. Caughey, L. M. Hopkins, and M. E. Norton, "Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss," Obstetrics and Gynecology, vol. 108, no. 3, part 1, pp. 612-616, 2006.
79. A. Tabor, C. H. F. Vestergaard, and Ø. Lidegaard, "Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study," Ultrasound in Obstetrics and Gynecology, vol. 34, no. 1, pp. 19-24, 2009.
80. L. G. Jackson, J. M. Zachary, S. E. Fowler et al., "A randomized comparison of transcervical and transabdominal chorionicvillus sampling," The New England Journal of Medicine, vol. 327, no. 9, pp. 594-598, 1992.
81. Y. M. Chan, D. S. Sahota, O. K. Chan, T. Y. Leung, and T. K. Lau, "Miscarriage after invasive prenatal diagnostic procedures: how much risk our pregnant women are willing to take?" Prenatal Diagnosis, vol. 29, no. 9, pp. 870-874, 2009.